ABBOTT LABORATORIES (ABT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 11,142 | 10,358 | 10,635 | 10,377 |
| Selling, general and administrative | 3,091 | 3,061 | 2,895 | 2,936 |
| Research and development | 725 | 716 | 713 | 698 |
| Cost of products sold, excluding amortization of intangible assets | 4,854 | 4,468 | 4,698 | 4,603 |
| Amortization of intangible assets | 420 | 420 | 470 | 471 |
| Total operating cost and expenses | 9,090 | 8,665 | 8,776 | 8,708 |
| Operating earnings | 2,052 | 1,693 | 1,859 | 1,669 |
| Interest (income) | 71 | 82 | 91 | 82 |
| Interest expense | 121 | 131 | 142 | 140 |
| Net foreign exchange (gain) loss | 11 | 7 | 11 | 6 |
| Other (income) expense, net | 137 | 127 | 121 | -10 |
| Earnings before taxes | 2,150 | 1,778 | 1,940 | 1,607 |
| Taxes on earnings | 371 | 453 | 294 | 305 |
| Net earnings | 1,779 | 1,325 | 1,646 | 1,302 |
| Average number of common shares outstanding plus dilutive common stock options (in shares) | 1,750,835,000 | 1,747,220,000 | 1,747,597,000 | 1,751,153,000 |
| Average number of common shares outstanding used for basic earnings per common share (in shares) | 1,743,437,000 | 1,739,206,000 | 1,739,466,000 | 1,743,040,000 |
| Basic earnings per common share (in dollars per share) | 1.02 | 0.76 | 0.94 | 0.74 |
| Diluted earnings per common share (in dollars per share) | 1.01 | 0.76 | 0.94 | 0.74 |